|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
10/19/2005 5:13:07 PM
BLUE BELL, Pa.--(BUSINESS WIRE)--March 24, 2005--InKine Pharmaceutical Company, Inc. (Nasdaq: INKP) today announced the election of John R. Leone to its Board of Directors.
Mr. Leone is currently President and Chief Executive Officer of Cambrex Corporation, a diversified life sciences company. Previously, Mr. Leone was Senior Vice President and Chief Operating Officer at Aventis Pharmaceuticals, Inc., where he was responsible for all U.S. Commercial Operations. Mr. Leone joined the Aventis predecessor company Rhone-Poulenc Rorer (RPR) in 1996 as Vice President and General Manager of the U.S. Prescription Products Division. He later became Senior Vice President and General Manager of RPR, responsible for all U.S. pharmaceutical businesses. Mr. Leone began his pharmaceutical career with Pfizer and American Home Products, holding marketing positions of increasing responsibility in the United States and Europe. He earned a B.S. in engineering from the United States Military Academy at West Point, New York and an M.B.A. with an emphasis in marketing from the University of Colorado.
|
|
|
|
|
|
|
|
|
|
|